Clinical Trials

NCT04098445 | RECRUITING

2000 participants

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

Study Type:

OBSERVATIONAL

Last Updated:

2026-06-22

Start Date:

2021-09-08

Completion:

2033-09-30

Conditions

• Hematopoietic Stem Cell Transplant (HSCT)
• Diffuse Alveolar Hemorrhage
• Thrombotic Microangiopathies
• Interstitial Pneumonitis
• Bronchiolitis Obliterans

No Results Yet

NCT04076748 | TERMINATED | PHASE3

115 participants

Evaluation of the Efficacy of Intra-nasal Sufentanil for Analgesia of Vaso-occlusive Crisis in Sickle-cell Adults.

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2021-07-20

Completion:

2024-07-21

Conditions

• Sickle Cell Crisis

Interventions

• DRUG

No Results Yet

NCT04049331 | RECRUITING | PHASE2

240 participants

Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2021-03-22

Completion:

2027-01-30

Conditions

• Hypogonadism, Male
• Fatigue Syndrome, Chronic

Interventions

• OTHER
• DRUG

No Results Yet

NCT03978767 | COMPLETED | PHASE2

287 participants

Preeclampsia And Nonsteroidal Drugs for Analgesia: a Randomized Non Inferiority Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2019-06-10

Completion:

2026-06-15

Conditions

• Preeclampsia Severe
• Preeclampsia Postpartum

Interventions

• DRUG

No Results Yet

NCT03967977 | ACTIVE_NOT_RECRUITING | PHASE3

420 participants

Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2019-05-29

Completion:

2027-06-30

Conditions

• Urothelial Carcinoma

Interventions

• DRUG

No Results Yet

NCT03841942 | TERMINATED | NA

64 participants

Comparison of Trough Level- and Clinical-based Spacing of Infliximab Infusions in Patients With IBD in Deep Remission

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2019-06-26

Completion:

2023-10-31

Conditions

• Inflammatory Bowel Diseases

Interventions

• OTHER

No Results Yet

NCT03838445 | ACTIVE_NOT_RECRUITING | NA

9 participants

Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2020-02-14

Completion:

2026-06-30

Conditions

• Pulmonary Arterial Hypertension

Interventions

• DEVICE

No Results Yet

NCT03735004 | COMPLETED | NA

45 participants

Transcranial Electrostimulation and Obstructive Sleep Apnea Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2017-07-18

Completion:

2024-01-11

Conditions

• Transcranial Electrical Stimulation

Interventions

• DEVICE

Results Available

NCT03699202 | TERMINATED | PHASE2

1 participants

Anti-RSV Study in Chinese Patients (ASCENT)

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2019-03-28

Completion:

2019-04-04

Conditions

• Respiratory Syncytial Virus Infections

Interventions

• DRUG

No Results Yet

NCT03675893 | RECRUITING | PHASE2

110 participants

RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2018-12-24

Completion:

2028-08-01

Conditions

• Endometrial Cancer

Interventions

• DRUG

No Results Yet

NCT03670966 | RECRUITING | PHASE1/PHASE2

30 participants

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2019-07-10

Completion:

2028-01-28

Conditions

• Acute Lymphoblastic Leukemia in Remission
• Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
• Acute Myeloid Leukemia in Remission
• Chronic Myelomonocytic Leukemia
• Myelodysplastic Syndrome With Excess Blasts
• Recurrent Acute Lymphoblastic Leukemia
• Recurrent Acute Myeloid Leukemia
• Refractory Acute Lymphoblastic Leukemia
• Refractory Acute Myeloid Leukemia
• Recurrent Mixed Phenotype Acute Leukemia
• Refractory Mixed Phenotype Acute Leukemia
• Hematopoietic and Lymphoid Cell Neoplasm

Interventions

• PROCEDURE
• DRUG
• BIOLOGICAL
• RADIATION

No Results Yet

NCT03651128 | COMPLETED | PHASE3

386 participants

Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2019-04-16

Completion:

2026-04-13

Conditions

• Multiple Myeloma

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT03619538 | COMPLETED | NA

80 participants

Interest of the Nefopam and PCA Morphine Combination for Postoperative Analgesia in Patients Undergoing Colon Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2007-06-30

Completion:

2007-06-25

Conditions

• Colonic Neoplasms
• Diverticulosis, Colonic

Interventions

• DRUG
• OTHER

No Results Yet

NCT03531073 | COMPLETED

446 participants

Multicentre ObservatioNal Initiative in Treat to Target Outcomes in Psoriatic Arthritis

Study Type:

OBSERVATIONAL

Last Updated:

2026-06-22

Start Date:

2018-04-18

Completion:

2024-12-31

Conditions

• Psoriatic Arthritis

Interventions

• DRUG

Results Available

NCT03485469 | COMPLETED | NA

60 participants

The Impact of the Hypnosis on the Loss of Weight at Patients in Failure of Bariatric Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2019-03-29

Completion:

2024-01-25

Conditions

• Obesity
• Bariatric Surgery

Interventions

• BEHAVIORAL

No Results Yet

NCT03476681 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

121 participants

Study of NEO-201 in Solid Tumors Expansion Cohorts

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2019-01-18

Completion:

2026-06-17

Conditions

• Non Small Cell Lung Cancer
• Head and Neck Squamous Cell Carcinoma
• Cervical Cancer
• Uterine Cancer

Interventions

• DRUG

No Results Yet

NCT03386240 | TERMINATED | PHASE4

1169 participants

Antibacterial-coated Sutures at Time of Cesarean

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2018-01-09

Completion:

2024-11-22

Conditions

• Surgical Site Infection
• Surgical Wound Infection
• Cesarean Section; Infection
• Cesarean Section Complications

Interventions

• DRUG
• OTHER

Results Available

NCT03334292 | RECRUITING

300 participants

Natural History of Wilson Disease

Study Type:

OBSERVATIONAL

Last Updated:

2026-06-22

Start Date:

2017-12-18

Completion:

2029-11-15

Conditions

• Wilson Disease

No Results Yet

NCT03301038 | RECRUITING | PHASE2

60 participants

Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2018-07-25

Completion:

2027-12-31

Conditions

• Idiopathic Infantile Hypercalcaemia - Severe Form
• Genetic Disease
• Hypercalcemia, Idiopathic, of Infancy
• Hypercalciuric Hypercalcemia
• Idiopathic Infantile Hypercalcemia - Mild Form
• Hypercalciuria

Interventions

• DRUG

No Results Yet

NCT03277729 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

53 participants

A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2017-12-05

Completion:

2024-03-29

Conditions

• Recurrent B-Cell Non-Hodgkin Lymphoma
• Recurrent Chronic Lymphocytic Leukemia
• Recurrent Diffuse Large B-Cell Lymphoma
• Recurrent Follicular Lymphoma
• Recurrent Lymphoplasmacytic Lymphoma
• Recurrent Mantle Cell Lymphoma
• Recurrent Marginal Zone Lymphoma
• Refractory B-Cell Non-Hodgkin Lymphoma
• Refractory Diffuse Large B-Cell Lymphoma
• Refractory Follicular Lymphoma
• Refractory Lymphoplasmacytic Lymphoma
• Refractory Mantle Cell Lymphoma
• Refractory Transformed Non-Hodgkin Lymphoma
• Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
• Recurrent Transformed Chronic Lymphocytic Leukemia
• Refractory Marginal Zone Lymphoma
• Refractory Transformed B-Cell Non-Hodgkin Lymphoma
• Refractory Transformed Chronic Lymphocytic Leukemia
• Recurrent Small Lymphocytic Lymphoma
• Refractory Chronic Lymphocytic Leukemia
• Refractory Small Lymphocytic Lymphoma
• Recurrent Central Nervous System Lymphoma
• Refractory Central Nervous System Lymphoma

Interventions

• BIOLOGICAL
• DRUG
• OTHER
• PROCEDURE

Results Available

NCT03250897 | COMPLETED

18 participants

Phenotypic Characterization of Alveolar Macrophages 2016 (Caract-Aires-2016)

Study Type:

OBSERVATIONAL

Last Updated:

2026-06-22

Start Date:

2016-11-30

Completion:

2017-12-01

Conditions

• Lung Diseases

No Results Yet

NCT03249870 | COMPLETED | PHASE2

131 participants

Study of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor ALL

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2017-12-28

Completion:

2024-10-17

Conditions

• Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP)

Interventions

• DRUG

No Results Yet

NCT03247023 | TERMINATED

65 participants

Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement

Study Type:

OBSERVATIONAL

Last Updated:

2026-06-22

Start Date:

2017-09-18

Completion:

2023-09-06

Conditions

• Degenerative Arthritis
• Rheumatoid Arthritis
• Traumatic Arthritis

Interventions

• DEVICE

Results Available

NCT03222531 | COMPLETED | PHASE2

20 participants

Expanding the Pool in Orthotopic Heart Transplantation

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2017-08-01

Completion:

2026-06-02

Conditions

• Hepatitis C
• Heart Transplant
• Cardiac Transplant

Interventions

• DRUG

No Results Yet

NCT03160794 | COMPLETED | NA

150 participants

Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2017-05-23

Completion:

2025-04-01

Conditions

• Post Prostatectomy

Interventions

• DIAGNOSTIC_TEST
• RADIATION

No Results Yet

NCT03128034 | RECRUITING | PHASE1/PHASE2

75 participants

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2017-10-24

Completion:

2027-06-30

Conditions

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
• Acute Myeloid Leukemia
• Chronic Myelomonocytic Leukemia
• Myelodysplastic Syndrome With Excess Blasts
• Recurrent Acute Myeloid Leukemia
• Refractory Acute Lymphoblastic Leukemia
• Recurrent Acute Lymphoblastic Leukemia
• Recurrent Mixed Phenotype Acute Leukemia
• Refractory Acute Myeloid Leukemia
• Refractory Mixed Phenotype Acute Leukemia
• Mixed Phenotype Acute Leukemia

Interventions

• DRUG
• PROCEDURE
• RADIATION

No Results Yet

NCT03110978 | ACTIVE_NOT_RECRUITING | PHASE2

140 participants

Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2017-06-26

Completion:

2028-06-30

Conditions

• Lung Atypical Carcinoid Tumor
• Lung Neuroendocrine Neoplasm
• Lung Non-Small Cell Squamous Carcinoma
• Minimally Invasive Lung Adenocarcinoma
• Neuroendocrine Carcinoma
• Recurrent Lung Adenocarcinoma
• Recurrent Lung Large Cell Carcinoma
• Recurrent Lung Non-Small Cell Carcinoma
• Stage I Lung Cancer AJCC v8
• Stage IA1 Lung Cancer AJCC v8
• Stage IA2 Lung Cancer AJCC v8
• Stage IA3 Lung Cancer AJCC v8
• Stage IB Lung Cancer AJCC v8
• Stage IIA Lung Cancer AJCC v8

Interventions

• BIOLOGICAL
• RADIATION

No Results Yet

NCT03097939 | ACTIVE_NOT_RECRUITING | PHASE2

113 participants

Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2017-03-31

Completion:

2027-04-05

Conditions

• Nasopharyngeal Carcinoma

Interventions

• DRUG

No Results Yet

NCT03044145 | COMPLETED | NA

54 participants

The Cultural Formulation Interview-Engagement Aid

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2016-09-20

Completion:

2018-09-05

Conditions

• Communication
• Adherence, Patient

Interventions

• BEHAVIORAL

Results Available

NCT02986074 | COMPLETED | NA

60 participants

CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2016-11-30

Completion:

2019-08-19

Conditions

• Chronic Pain

Interventions

• DEVICE

Results Available

NCT02918253 | ACTIVE_NOT_RECRUITING | NA

60 participants

HDR Focal: Feasibility Study

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2016-10-14

Completion:

2027-11-30

Conditions

• Prostate Cancer

Interventions

• RADIATION

No Results Yet

NCT02898961 | COMPLETED | PHASE4

63 participants

Impact of 30 mg/kg Amikacin and 8 mg/kg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2014-10-31

Completion:

2016-12-31

Conditions

• Sepsis

Interventions

• DRUG

No Results Yet

NCT02897908 | RECRUITING

1000 participants

Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database

Study Type:

OBSERVATIONAL

Last Updated:

2026-06-22

Start Date:

2016-10-28

Completion:

2027-04-30

Conditions

• Disease of Liver and Bile Duct

Interventions

• PROCEDURE

No Results Yet

NCT02887001 | COMPLETED | NA

500 participants

Impact of Clinical Pharmacist on the Quality and Cost of the Therapeutic Management of Patients in Two Medical Services of a Teaching Hospital

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2011-06-30

Completion:

2012-07-01

Conditions

• Admitted to Infectiology or Internal Medicine Wards

Interventions

• OTHER

No Results Yet

NCT02854982 | COMPLETED

900 participants

Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer

Study Type:

OBSERVATIONAL

Last Updated:

2026-06-22

Start Date:

2015-09-01

Completion:

2017-07-31

Conditions

• Prostatic Neoplasms
• Quality of Life

Interventions

• PROCEDURE

No Results Yet

NCT02848768 | COMPLETED

45 participants

Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma

Study Type:

OBSERVATIONAL

Last Updated:

2026-06-22

Start Date:

2014-12-31

Completion:

2015-03-31

Conditions

• Metastatic Clear Cell Renal Cell Carcinoma

Interventions

• DRUG

No Results Yet

NCT02817789 | TERMINATED | PHASE3

50 participants

Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI)

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2016-05-09

Completion:

2018-05-30

Conditions

• Aortic Valve Stenosis

Interventions

• DRUG

No Results Yet

NCT02675374 | TERMINATED | PHASE3

18 participants

Hemodynamic Instability Prevented With Polaramine® Infusion Before Extracorporeal Circulation

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2016-06-05

Completion:

2017-07-18

Conditions

• Hemodynamic Instability
• Vasoplegic Syndrome

Interventions

• DRUG

No Results Yet

NCT02526212 | COMPLETED | PHASE3

18 participants

Buprenorphine Group Medical Visits in Primary Care

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2017-01-01

Completion:

2019-05-31

Conditions

• Opioid-Related Disorders

Interventions

• BEHAVIORAL
• DRUG

Results Available

NCT02491099 | RECRUITING | PHASE2

50 participants

A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-06-22

Start Date:

2015-06-30

Completion:

2026-12-31

Conditions

• HER2/Neu+ Uterine Serous Carcinoma

Interventions

• DRUG

No Results Yet